4//SEC Filing
Westlake BioPartners Fund I, L.P. 4
Accession 0001104659-25-123596
CIK 0001994702other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 11:42 AM ET
Size
12.1 KB
Accession
0001104659-25-123596
Insider Transaction Report
Form 4
Transactions
- Purchase
Common Stock
2025-12-18$7.50/sh+133,333$999,998→ 869,317 total(indirect: See Footnote)
Holdings
- 3,787,940(indirect: See Footnote)
Common Stock
Transactions
- Purchase
Common Stock
2025-12-18$7.50/sh+133,333$999,998→ 869,317 total(indirect: See Footnote)
Holdings
- 3,787,940(indirect: See Footnote)
Common Stock
Westlake BioPartners Fund I, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2025-12-18$7.50/sh+133,333$999,998→ 869,317 total(indirect: See Footnote)
Holdings
- 3,787,940(indirect: See Footnote)
Common Stock
Westlake BioPartners GP I, LLC
10% Owner
Transactions
- Purchase
Common Stock
2025-12-18$7.50/sh+133,333$999,998→ 869,317 total(indirect: See Footnote)
Holdings
- 3,787,940(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]Shares held directly by Westlake BioPartners Opportunity Fund I, L.P. ("Westlake Opportunity"). The general partner of Westlake Opportunity is Westlake BioPartners Opportunity GP I, LLC ("Westlake Opportunity GP I"). The voting and dispositive control over Westlake Opportunity GP I is held by the managing director of Westlake Opportunity GP I, Beth Seidenberg, and whom disclaims beneficial ownership of the shares held by Westlake Opportunity except to the extent of such person's pecuniary interest therein, if any. Sean Harper, a Reporting Person on Westlake Opportunity's prior Section 16 filings with respect to the Issuer, is no longer a managing director of Westlake Opportunity GP I, and accordingly, is not a Reporting Person on this Form 4.
- [F2]Shares held directly by Westlake BioPartners Fund I, L.P. ("Westlake I"). The general partner of Westlake I is Westlake BioPartners GP I, LLC ("Westlake GP I"). The voting and dispositive control over Westlake GP I is held by the managing director of Westlake GP I, Beth Seidenberg, and whom disclaims beneficial ownership of the shares held by Westlake I except to the extent of such person's pecuniary interest therein, if any. Sean Harper, a Reporting Person on Westlake I's prior Section 16 filings with respect to the Issuer, is no longer a managing director of Westlake GP I, and accordingly, is not a Reporting Person on this Form 4.
Documents
Issuer
Kyverna Therapeutics, Inc.
CIK 0001994702
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001749591
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 11:42 AM ET
- Size
- 12.1 KB